eJHaem (Aug 2022)

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma

  • Esther E. E. Drees,
  • Julia Driessen,
  • Gerben J. C. Zwezerijnen,
  • Sandra A. W. M. Verkuijlen,
  • Jakoba J. Eertink,
  • Monique A. J. vanEijndhoven,
  • Nils J. Groenewegen,
  • Andrea Vallés‐Martí,
  • Daphne deJong,
  • Ronald Boellaard,
  • Henrica C. W. deVet,
  • Dirk M. Pegtel,
  • Josée M. Zijlstra

DOI
https://doi.org/10.1002/jha2.432
Journal volume & issue
Vol. 3, no. 3
pp. 908 – 912

Abstract

Read online

Abstract Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative 18F‐FDG‐PET features. We correlated extracellular vesicle‐associated miRNAs (EV‐miRNA), serum TARC, and complete blood count (CBC) with PET features (e.g., metabolic tumor volume [MTV], dissemination and intensity features) in 30 cHL patients at baseline. EV‐miR127‐3p, EV‐miR24‐3p, sTARC, and several CBC parameters showed weak to strong correlations with MTV and dissemination features, but not with intensity features. Two other EV‐miRNAs only showed weak correlations with PET features. Therefore, blood‐based biomarkers may be complementary to PET features, which warrants further exploration of combining these biomarkers in prognostic models.

Keywords